AEON Biopharma, Inc. (AEON)
NYSEAMERICAN: AEON · Real-Time Price · USD
0.9487
-0.0914 (-8.78%)
At close: Feb 12, 2026, 4:00 PM EST
0.9593
+0.0107 (1.12%)
After-hours: Feb 12, 2026, 4:24 PM EST
AEON Biopharma Market Cap
AEON Biopharma has a market cap or net worth of $24 million as of February 12, 2026. Its market cap has increased by 132.14% in one year.
Market Cap
24.00M
Enterprise Value
36.35M
1-Year Change
132.14%
Ranking
Category
Stock Price
$0.95
Market Cap Chart
Since April 12, 2021, AEON Biopharma's market cap has decreased from $63.66M to $24.00M, a decrease of -62.29%. That is a compound annual growth rate of -18.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 26.32M | 102.08% |
| Dec 31, 2025 | 13.02M | -39.67% |
| Dec 31, 2024 | 21.58M | -91.93% |
| Dec 29, 2023 | 267.55M | -80.82% |
| Dec 30, 2022 | 1.40B | 553.24% |
| Dec 30, 2021 | 213.58M | 235.51% |
| Apr 12, 2021 | 63.66M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Barinthus Biotherapeutics | 28.99M |
| Evaxion | 28.65M |
| Exicure | 27.47M |
| Palatin Technologies | 27.24M |
| IO Biotech | 26.41M |
| BriaCell Therapeutics | 26.34M |
| Marker Therapeutics | 25.84M |
| Rallybio | 25.77M |